SCHEMBL3213869

SCHEMBL3213869

COc1ccc(C=CC(=O)CC(=O)C=Cc2ccc(N(C)C)c(OC)c2)cc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.74
APP P05067 2/20 0.74
BACE1 P56817 12/20 0.72
CYP2D6 P10635 2/20 0.65
CYP2C9 P11712 2/20 0.65
TSHR P16473 2/20 0.65
HSD17B10 Q99714 2/20 0.65
MMP9 P14780 2/20 0.65
NFE2L2 Q16236 2/20 0.65
CA1 P00915 2/20 0.65
CA2 P00918 2/20 0.65
MEN1 O00255 2/20 0.65
ALDH1A1 P00352 2/20 0.65
THRB P10828 2/20 0.65
KMT2A Q03164 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
ABCB1 P08183 2/20 0.65
AKR1B1 P15121 2/20 0.65
MAOA P21397 2/20 0.65
MAOB P27338 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3213847 1.00 MAPT (0.74) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3216853 0.92 NFE2L2 (0.70) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3216888 0.92 NFE2L2 (0.70) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3211168 0.91 APP (0.80) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3211184 0.91 APP (0.80) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3211207 0.89 CA1 (0.73) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3211190 0.89 CA1 (0.73) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL5599057 0.88 MAPT (0.89) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL2622437 0.88 MAPT (0.89) MAPTAPPBACE1CYP2D6CYP2C9
SCHEMBL3221668 0.86 MMP9 (0.81) MAPTAPPBACE1CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 MAPT 8/4885APP 2/4885BACE1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.